New: NCI-funded clinical trial search
Mednet Logo
CommunityHematology

Would you recommend ISRT for an initially bulky nodular lymphocyte predominant Hodgkin lymphoma with complete metabolic response after 4 cycles of R-CHOP?

What if the patient were a young adult male with disease in the pelvic lymph nodes?
3 Answers
Mednet MemberInvited Expert
Radiation Oncology · Duke University Medical Center
Answered on

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma. Approximately 95% of Hodgkin lymphoma cases are classified as classic Hodgkin lymphoma, including the nodular sclerosis, mixed cellularity, lymphocyte-rich, and lymphocyte-depleted subtypes, all of which are generally managed similarly. The remaining 5% of cases represent NLPHL, which is often approached differently from classic Hodgkin lymphoma. For patients with stage IA disease, RT alone provides du...

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Radiation Oncology · Duke University Medical Center
Answered on

NLPHL is an uncommon variety of HL. Its biology is not well understood, but the disease is generally CD20 positive and closely related to nodular NHL. For early-stage disease, NCCN guidelines recommend ISRT alone in most cases. Chemotherapy does not appear to improve outcome when added to RT for early-stage disease. As in nodular NHL, chemotherapy does not appear to be curative for most patients with NLPHL.

The question does not specify the stage of disease. Assuming early stage, I would recomme...

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Radiation Oncology · University Hospital Basel
Answered on

Yes, I would.

With the exception of early stage with no risk factors, nodular lymphocyte predominant HL should be treated according to what is known for "typical" HL.

Consolidative RT will lower the risk of recurrence in this patient.

Join for free or sign in to see the full answer